12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Loading...
Loading...

 

Gainers

  • vTv Therapeutics VTVT stock increased by 72.3% to $0.95 during Wednesday's pre-market session. The market value of their outstanding shares is at $63.5 million.
  • Tonix Pharmaceuticals TNXP shares rose 27.45% to $3.11. The market value of their outstanding shares is at $58.2 million.
  • Endo International ENDP stock rose 18.21% to $0.62. The market value of their outstanding shares is at $146.6 million.
  • Strata Skin Sciences SSKN stock rose 16.36% to $1.28. The market value of their outstanding shares is at $44.4 million.
  • Vyant Bio VYNT shares moved upwards by 15.37% to $0.82. The market value of their outstanding shares is at $24.0 million.
  • Orchard Therapeutics ORTX shares rose 9.81% to $0.5. The company's market cap stands at $62.9 million.

Losers

  • Concert Pharma CNCE stock declined by 18.2% to $5.2 during Wednesday's pre-market session. The market value of their outstanding shares is at $188.9 million.
  • Enochian BioSciences ENOB shares declined by 16.35% to $4.4. The market value of their outstanding shares is at $232.9 million.
  • Kiora Pharmaceuticals KPRX stock fell 13.64% to $0.38. The market value of their outstanding shares is at $4.8 million.
  • MoonLake MLTX shares decreased by 13.46% to $6.69. The market value of their outstanding shares is at $247.0 million.
  • Outlook Therapeutics OTLK shares fell 13.05% to $1.0. The market value of their outstanding shares is at $225.9 million.
  • Stealth BioTherapeutics MITO shares fell 12.46% to $0.24. The market value of their outstanding shares is at $14.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: Pre-Market OutlookMarketsMoversBZI-TFM
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...